Cardlytics, INC Form 4 insider transactions

Clifford Sosin, through CAS Investment Partners, sold 31,300 shares of Cardlytics stock across two days, while maintaining indirect ownership of a significant number of shares and convertible notes.

Clifford Sosin, a director of Cardlytics, Inc., reported a transaction involving the company's convertible senior notes and potential underlying common stock.

Clifford Sosin, a director at Cardlytics, sold 19,523 shares of common stock at $3.953 per share, while still holding a significant indirect stake through investment partnerships.

Cardlytics' Chief Financial Officer, Alexis DeSieno, sold 25,118 shares of common stock to cover tax obligations following the vesting of restricted stock units.

Director Srishti A. Gupta acquired 6,148 restricted stock units (RSUs) of Cardlytics, Inc. on October 30, 2024, which will vest in full on the one-year anniversary of the grant date.

Cardlytics CEO Amit Gupta sold shares to cover tax obligations following the vesting of restricted stock units (RSUs).

Cardlytics' Chief Financial Officer, Alexis DeSieno, reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Cardlytics' Chief Legal & Privacy Officer, Nicholas Hollmeyer Lynton, reports acquisition and disposal of common stock and restricted stock units to cover tax obligations.

Cardlytics CEO Amit Gupta reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Director Scott A. Hill reports the vesting and conversion of restricted stock units into Cardlytics common stock.

Cardlytics' CEO, Amit Gupta, was granted 500,000 restricted stock units (RSUs) on August 21, 2024, according to a Form 4 filing with the SEC.

Cardlytics' Chief Financial Officer, Alexis DeSieno, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Director Scott A. Hill purchased 40,000 shares of Cardlytics, Inc. (CDLX) at $3.58 per share on August 12, 2024.

Director Liane Hornsey purchased 10,000 shares of Cardlytics, Inc. (CDLX) at $3.59 per share on August 12, 2024.

Director John L. Klinck Jr. of Cardlytics, Inc. (CDLX) purchased 14,000 shares of common stock at $3.49 per share on August 12, 2024.

Cardlytics' Chief Operating Officer, Amit Gupta, sold shares to cover tax obligations arising from the vesting of restricted stock units.

Cardlytics' Chief Legal & Privacy Officer, Nicholas Hollmeyer Lynton, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Cardlytics' Chief Operating Officer, Amit Gupta, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Cardlytics' Chief Financial Officer, Alexis DeSieno, reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.

Clifford Sosin, Managing Member of CAS Investment Partners, reports a pro rata distribution of Cardlytics (CDLX) shares from Sosin Master, L.P. to its partners.

Cardlytics CEO Karim Temsamani reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Director Scott A. Hill acquired 11,000 restricted stock units in Cardlytics, Inc. on May 23, 2024.

Director Liane Hornsey acquired 11,000 restricted stock units in Cardlytics, Inc. on May 23, 2024, which will vest in full on the one-year anniversary of the grant date.

Director Jonathan Edward Francis acquired 11,000 restricted stock units in Cardlytics, Inc. on May 23, 2024.

Director Andre J. Fernandez acquired 11,000 restricted stock units in Cardlytics, Inc. on May 23, 2024.

Director John L. Klinck Jr. reports acquisition and disposal of Cardlytics (CDLX) stock and restricted stock units on May 23, 2024.

Director Jessica Jensen reports the acquisition and disposal of Cardlytics (CDLX) common stock related to restricted stock units.

Director Aimee Lapic reports the vesting and disposal of restricted stock units (RSUs) into Cardlytics, Inc. common stock on May 23, 2024.

Clifford Sosin, Managing Member of CAS Investment Partners, amends his Form 4 filing to report transactions in Cardlytics, Inc. stock and convertible notes, and agrees to disgorge profits from these transactions.

Clifford Sosin, Managing Member of CAS Investment Partners, reports increased beneficial ownership in Cardlytics, Inc. through recent common stock purchases and holdings of convertible senior notes.